[Drug monitoring in neurology (author's transl)]. 1980

F Eckmann

Medication and side-effects were investigated in 115 hospitalized epileptic patients. General side-effects were registered in 12.7%, however, only 5.6% were obviously drug-induced. Supposing that 8 anticonvulsive drugs are used frequently, then, 256 combinations of these drugs could occur. In order to obtain relevant results on the comparative frequency of adverse drug reactions for any of these combinations, a population of at least 8000 patients should have to be monitored. Further difficulties arise as regards the expected probability of the coincidence of adverse drug reactions and the frequency of a special medication.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

F Eckmann
April 1982, Rinsho byori. The Japanese journal of clinical pathology,
F Eckmann
January 1980, Arzneimittel-Forschung,
F Eckmann
July 1980, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
F Eckmann
September 1980, MMW, Munchener medizinische Wochenschrift,
F Eckmann
February 1974, Fortschritte der Neurologie, Psychiatrie, und ihrer Grenzgebiete,
F Eckmann
July 1977, MMW, Munchener medizinische Wochenschrift,
F Eckmann
May 1977, MMW, Munchener medizinische Wochenschrift,
F Eckmann
April 1982, Rinsho byori. The Japanese journal of clinical pathology,
F Eckmann
January 1981, Acta neurologica Belgica,
Copied contents to your clipboard!